Search

Your search keyword '"Violin, Michela"' showing total 37 results

Search Constraints

Start Over You searched for: Author "Violin, Michela" Remove constraint Author: "Violin, Michela"
37 results on '"Violin, Michela"'

Search Results

1. Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management

3. Secondary Mutations in the Protease Region of Human Immunodeficiency Virus and Virologic Failure in Drug-Naive Patients Treated with Protease Inhibitor-Based Therapy

4. Identification of Two Distinct Subsets of Long-Term Nonprogressors with Divergent Viral Activity by Stromal-Derived Factor 1 Chemokine Gene Polymorphism Analysis

5. The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes

6. Increasing prevalence of non-clade B HIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequences

7. Prevalence of multiple dideoxynucleoside analogue resistance (MddNR) in a multicenter cohort of HIV-1-infected Italian patients with virologic failure

8. Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management

10. Minor mutations in HIV protease at baseline and appearance of primary mutation 90M in patients for whom their first protease-inhibitor antiretroviral regimens failed

12. Secondary mutations in the protease region of Human Immunodeficiency Virus and virologic failure in drug-naive patients treated with protease inhibitor--based therapy

16. Identification of a new HIV-1 BC circulating recombinant form (CRF60_BC) in Italian young men having sex with men

17. Evidence of differential selection of HIV-1 variants carrying drug-resistant mutations in seroconverters

18. Transmission of Resistant HIV Type 1 Variants and Epidemiological Chains in Italian Newly Diagnosed Individuals

19. Transmitted HIV Type 1 Drug Resistance and Non-B Subtypes Prevalence among Seroconverters and Newly Diagnosed Patients from 1992 to 2005 in Italy

21. Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection

23. Prevalence of HIV-1 Primary Drug Resistance in Seroconverters of the ICoNA Cohort Over the Period 1996???2001

25. Susceptibility to PNU-140690 (Tipranavir) of Human Immunodeficiency Virus Type 1 Isolates Derived from Patients with Multidrug Resistance to Other Protease Inhibitors

26. Prevalence of Transmitted Nucleoside Analogue-Resistant HIV-1 Strains and Pre-Existing Mutations in Pol Reverse Transcriptase and Protease Region: Outcome after Treatment in Recently Infected Individuals

27. Comparable Biological and Molecular Determinants in HIV Type 1-Infected Long-Term Nonprogressors and Recently Infected Individuals

28. Plasma viremia and virus phenotype are correlates of disease progression in vertically human immunodeficiency virus type 1-infected children

29. Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection

30. Impact of Mutations Conferring Reduced Susceptibility to Lamivudine on the Response to Antiretroviral Therapy

31. Prevalence of Transmitted Nucleoside Analogue-Resistant HIV-1 Strains and Pre-Existing Mutations in PolReverse Transcriptase and Protease Region: Outcome after Treatment in Recently Infected Individuals

32. Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection

33. Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management

34. Identification of Two Distinct Subsets of Long-Term Nonprogressors with Divergent Viral Activity by Stromal-Derived Factor 1 Chemokine Gene Polymorphism Analysis.

35. Evidence of differential selection of HIV-1 variants carrying drug-resistant mutations in seroconverters.

36. Prevalence of HIV-1 primary drug resistance in seroconverters of the ICoNA cohort over the period 1996-2001.

37. Fulminant myocarditis during HIV seroconversion: recovery with temporary left ventricular mechanical assistance.

Catalog

Books, media, physical & digital resources